OK, I follow Akki's comment regarding the wish/attraction of unheralded development being more attractive to the interests of Big Pharma.
Surely the actual proven IP accounts for the most significant attraction value.
My vote would be to promote for, and then hold, the "upfront" fee I believe PYC could command within the next 9months -given the positive due-diligence Dr Robert Hayes and Dr Rick Kendall convey with their committed association. GLTA
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
-0.020(1.56%) |
Mkt cap ! $737.8M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.25 | $4.616M | 3.649M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19940 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 1008 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |